Source - SMW
Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1900p (from 2000p).

Related Charts

GlaxoSmithKline (GSK)

-6.75p (-0.43%)
delayed 18:15PM